Sun Pharma Advanced Research Company reports consolidated net loss of Rs 75.85 crore in the September 2025 quarter
(11 Nov 2025)

Back
Net Loss of Sun Pharma Advanced Research Company reported to Rs 75.85 crore in the quarter ended September 2025 as against net loss of Rs 107.33 crore during the previous quarter ended September 2024. Sales declined 38.88% to Rs 7.86 crore in the quarter ended September 2025 as against Rs 12.86 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales7.8612.86 -39
OPM %-836.13-800.23 -
PBDT-73.23-104.01 30
PBT-75.79-107.17 29
NP-75.85-107.33 29

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew